Clinical trials data
Symbol Coding in mild cognitive impairment trials: 84 registered studies
Every registered mild cognitive impairment study on ClinicalTrials.gov that names Symbol Coding in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered mild cognitive impairment studies name it in an outcome measure
- 84
- Name it in a primary outcome, 45%
- 38 of 84
Tests named in the same studies
- 1
Trail Making Test42 studies, 22 as a primary outcome
- 2
Verbal Fluency34 studies, 16 as a primary outcome
- 3
Digit Span Test32 studies, 20 as a primary outcome
- 4
Verbal Learning28 studies, 16 as a primary outcome
- 5
Category Fluency26 studies, 15 as a primary outcome
- 6
Short Story Recall22 studies, 12 as a primary outcome
- 7
Stroop Color-Word Test18 studies, 8 as a primary outcome
- 8
Selective Reminding Task14 studies, 5 as a primary outcome
- 9
Picture Naming Test11 studies, 6 as a primary outcome
- 10
Clock Drawing Task10 studies, 5 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 2 | 1 |
| 2010 | 1 | 0 |
| 2011 | 3 | 0 |
| 2012 | 4 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 3 | 2 |
| 2017 | 2 | 1 |
| 2018 | 3 | 3 |
| 2019 | 2 | 1 |
| 2020 | 3 | 2 |
| 2021 | 15 | 7 |
| 2022 | 7 | 3 |
| 2023 | 11 | 4 |
| 2024 | 12 | 8 |
| 2025 | 10 | 3 |
| 2026 | 3 | 0 |
Phases and study sizes
By phase
- Phase 11 studies, 0 as a primary outcome
- Phase 1/21 studies, 0 as a primary outcome
- Phase 215 studies, 6 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 32 studies, 2 as a primary outcome
- Phase 41 studies, 1 as a primary outcome
- Not applicable60 studies, 28 as a primary outcome
- Observational3 studies, 1 as a primary outcome
Participants per study
- Phase 278 median, 50 to 200
- Not applicable85 median, 45 to 180
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 13 | 78 | 50 to 200 |
| Not applicable | 60 | 85 | 45 to 180 |
When mild cognitive impairment trials measure it
Latest time point of each outcome
- Within a day2 outcomes, 2 as a primary outcome
- Up to 4 weeks6 outcomes, 1 as a primary outcome
- 1 to 3 months20 outcomes, 11 as a primary outcome
- 3 to 6 months18 outcomes, 9 as a primary outcome
- 6 to 12 months19 outcomes, 7 as a primary outcome
- 1 to 2 years9 outcomes, 4 as a primary outcome
- Over 2 years5 outcomes, 1 as a primary outcome
- No duration given5 outcomes, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
79 of the 84 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting17 studies, 8 as a primary outcome
- Not yet recruiting6 studies, 3 as a primary outcome
- Active, not recruiting5 studies, 3 as a primary outcome
- Completed36 studies, 14 as a primary outcome
- Stopped early4 studies, 1 as a primary outcome
- Status unknown16 studies, 9 as a primary outcome
What they test
- Behavioral28 studies, 11 as a primary outcome
- Drug16 studies, 7 as a primary outcome
- Device17 studies, 4 as a primary outcome
- Dietary supplement8 studies, 6 as a primary outcome
- Procedure1 studies, 0 as a primary outcome
- Diagnostic test2 studies, 1 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Combination product4 studies, 4 as a primary outcome
- Genetic1 studies, 0 as a primary outcome
- Other20 studies, 13 as a primary outcome
- None given1 studies, 0 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States34 studies, 15 as a primary outcome
- Greece6 studies, 5 as a primary outcome
- Spain6 studies, 4 as a primary outcome
- Canada4 studies, 2 as a primary outcome
- China4 studies, 0 as a primary outcome
- France4 studies, 3 as a primary outcome
- Germany4 studies, 3 as a primary outcome
- Italy4 studies, 1 as a primary outcome
- Taiwan4 studies, 2 as a primary outcome
- Australia3 studies, 2 as a primary outcome
- South Korea3 studies, 0 as a primary outcome
- United Kingdom3 studies, 2 as a primary outcome
29 countries in all. A study with sites in several counts in each; 6 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed mild cognitive impairment studies that name Symbol Coding: 19 of 36, 53%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed mild cognitive impairment studies that name Symbol Coding | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 6, 17% | 776, 10% |
| Results on ClinicalTrials.gov only | 6, 17% | 1,139, 14% |
| A results paper only | 7, 19% | 1,711, 22% |
| Neither | 17, 47% | 4,327, 54% |
The 84 studies
84 studies match. 38 name Symbol Coding in a primary outcome. Median size 93 participants. Median time to the primary outcome: 6 months.
Loading 84 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 2 | 1 |
| 2010 | 1 | 0 |
| 2011 | 3 | 0 |
| 2012 | 4 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 3 | 2 |
| 2017 | 2 | 1 |
| 2018 | 3 | 3 |
| 2019 | 2 | 1 |
| 2020 | 3 | 2 |
| 2021 | 15 | 7 |
| 2022 | 7 | 3 |
| 2023 | 11 | 4 |
| 2024 | 12 | 8 |
| 2025 | 10 | 3 |
| 2026 | 3 | 0 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 12, other 72. Interventional 81, observational 3.
As a primary outcomeSecondary or other outcomeSymbol Coding
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07856043 | Start2026 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Cardiovascular disease | Participants18 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07842146 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07651787 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07497334 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07241598 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06977815 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants70 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06935812 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants106 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06854731 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise | Participants328 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06825403 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06773416 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise, Sleep and sleep disorders | Participants206 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06719297 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06601933 | Start2024 | PhasePhase 2 | ConditionsMild cognitive impairment | Participants240 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06413173 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment, Brain injury and concussion | Participants160 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06408103 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants102 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06399731 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment, Parkinson's disease | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06375720 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants350 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06347315 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants380 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT06278688 | Start2024 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants120 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06155721 | Start2023 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants45 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06112639 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Multiple sclerosis, Cancer | Participants192 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06083350 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants144 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06041152 | Start2023 | PhasePhase 2 | ConditionsMild cognitive impairment | Participants10 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05997316 | Start2023 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants33 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many mild cognitive impairment trials use Symbol Coding?
84 registered mild cognitive impairment studies on ClinicalTrials.gov name it in an outcome measure, 38 of them in a primary outcome: 10% of the condition's 859 studies with a cognitive outcome, against 9% of all of them. It is the 7th most named test in mild cognitive impairment trials.
Which tests do mild cognitive impairment trials use with Symbol Coding?
The Trail Making Test (42 studies), Verbal Fluency (34 studies) and the Digit Span Test (32 studies).
How many participants do phase 2 mild cognitive impairment trials that use Symbol Coding enroll?
Half of the phase 2 studies that name it enroll 78 participants or fewer, and the middle half enroll 50 to 200. 13 of them give a size.
When do mild cognitive impairment trials measure Symbol Coding?
Half of the primary outcomes that name Symbol Coding are measured within 6 months of the start, and the middle half from 12 weeks to 12 months. 35 primary outcomes give a duration.
How many completed mild cognitive impairment trials that use Symbol Coding have reported results?
19 of the 36 completed studies that name it, 53%, have reported results: 12 posted them on ClinicalTrials.gov, 13 have a results paper linked to the registry record, and 6 did both. The other 17 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Symbol Key Game and Symbol Coding as one test family, so this page counts their studies together.
Run Symbol Coding in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.